19 June 2012 08:19 [Source: ICIS news]
SINGAPORE (ICIS)--DSM has acquired all outstanding shares of US-based medical firm Kensey Nash at $38.50 (€30.40) per share, the Dutch specialty chemicals firm said on Tuesday.
The acquisition was made through a tender offer, which expired on 18 June, DSM said in a statement.
DSM expects to close the acquisition within “the next few days”, the company said.
Kensey Nash is largely focused on the manufacture of regenerative medicine utilising its proprietary collagen and synthetic polymer technology, it said.
($1 = €0.79)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections